Learn More
Medchemexpress LLC ICL-CCIC-0019 10mg | 936498-64-5 | 572.46 g/mol | C26H44Br2N4 | 10 MG

Supplier: Medchemexpress LLC HY11584010MG
ICL-CCIC-0019 is a small-molecule inhibitor of choline kinase α (CHKα) used in preclinical cancer research. It decreases phosphocholine levels and induces G1 cell-cycle arrest, endoplasmic reticulum stress, and apoptosis in cancer cell lines.
- Inhibits choline kinase α (CHKα) activity.
- Induces G1 cell-cycle arrest and apoptosis in cancer cell lines.
- Confirmed purity by HPLC: 95.38%.
- Provided as a dibromide pyridinium salt (C26H44Br2N4).
- Store sealed at -20°C; in solvent, store at -80°C up to 6 months.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.